Beyond Finding What Is Wrong
When patients attend a musculoskeletal assessment, the focus is naturally on the pain — where it is, what caused it, and what is generating it. But skilled clinical assessment addresses an equally important question: how is the person functioning? Strength and mobility testing answers this question, providing quantifiable, objective data about what the body can and cannot do — independent of what the patient reports subjectively and independent of what imaging may or may not show. This functional data is essential for accurate diagnosis, for identifying contributing factors and maintaining vulnerabilities, and for designing rehabilitation programmes that address the real drivers of the presentation rather than just its symptoms.
What Mobility Testing Reveals
Range of motion testing at each relevant joint establishes whether restriction is present, how it compares to the expected norm and to the contralateral side, and — crucially — what the quality of restriction is. Pain-limited restriction (the patient can move further but stops due to pain) suggests an acute inflammatory process or a sensitised pain state rather than a structural mechanical block. Mechanically limited restriction with a soft end-feel suggests muscle or soft tissue tightening; with a hard end-feel, joint capsule thickening or osteophytic blocking; with an empty end-feel (patient stops before a mechanical barrier due to apprehension), acute pathology such as a fracture or significant ligamentous injury.
The pattern of restriction across multiple movements at a joint provides more diagnostic information than any single restricted movement. A capsular pattern (loss across multiple directions in a predictable ratio) indicates global joint capsule involvement. A non-capsular pattern suggests involvement of specific structures — one muscle, one ligament, one compartment — rather than the capsule as a whole. Combined movement testing (combining flexion with rotation, or flexion with side-bending) can selectively stress specific spinal and peripheral structures that may not be challenged by single-plane movements.
What Strength Testing Reveals
Muscle strength testing serves multiple clinical purposes simultaneously. Detecting weakness: specific muscle weakness confirms dysfunction in the relevant myotome (for neurological presentations) or identifies local inhibition from pain, disuse, or injury. The multifidus weakness reliably found at affected lumbar levels following disc injury, the quadriceps inhibition characteristic of knee joint pathology, and the lower trapezius insufficiency so common in shoulder presentations are all clinically significant contributors to ongoing dysfunction that would not be identified without targeted strength testing.
Localising pathology: the pattern of which movements are strong and which are weak provides diagnostic information about the specific structures involved. In rotator cuff assessment, testing external rotation (infraspinatus and teres minor), internal rotation (subscapularis), and abduction (supraspinatus) in specific positions allows the clinician to identify which muscle is contributing to the dysfunction. Assessing pain reproduction: resisted muscle testing — applying resistance without joint movement — challenges the contractile component of the musculotendinous unit in isolation from articular structures. Pain on resisted testing implicates the muscle belly or myotendinous junction; pain on passive testing implicates the capsule, ligament, or bursae. This distinction guides the specificity of treatment.
Neurological Significance
In presentations with possible neural involvement — radiculopathy, peripheral nerve entrapment, myelopathy — strength testing is not merely functional but diagnostic. Specific patterns of muscle weakness map onto specific spinal levels or peripheral nerves, allowing the clinician to localise the level or site of neural compromise. L5 radiculopathy produces weakness of the extensor hallucis longus and hip abductors; S1 radiculopathy produces weakness of the peronei and plantar flexors; C6 radiculopathy produces biceps and wrist extensor weakness. Combined with dermatomal sensory testing and reflex assessment, strength testing in this context provides the neurological examination that determines whether imaging referral, medical review, or conservative management is the appropriate next step.
Establishing Baselines and Tracking Progress
Beyond diagnosis, quantified strength and mobility testing establishes objective baselines that enable meaningful tracking of progress through rehabilitation. Subjective reports of improvement are valuable but can be influenced by therapeutic alliance, expectation, and variable symptom expression on different days. Objective measurement — "your hip flexion has increased from 60° to 95° passive range over four sessions; your hip abduction strength has increased from 3.5/5 to 4.5/5" — provides both the clinician and the patient with unambiguous evidence of change, guides decisions about progressing or modifying the programme, and informs timely referral when expected improvement is not occurring. In legal and insurance contexts, documented objective findings are also essential for supporting clinical decisions.
The functional screen: Single-leg squat, hip hinge, and overhead press movement quality tests reveal neuromuscular control patterns that are not captured by isolated joint range of motion or strength testing — they show how the body integrates strength and mobility under the functional demands of real movement.
Why Testing Beats Imaging for Most Presentations
For the vast majority of musculoskeletal presentations, functional strength and mobility testing provides more clinically actionable information than imaging. Imaging reveals structural changes in tissue — but structural changes in the absence of corroborating clinical findings have limited diagnostic value, because asymptomatic structural abnormalities (disc bulges, rotator cuff tears, labral fraying, articular cartilage changes) are ubiquitous across the adult population and frequently bear no relationship to the patient's symptoms. Functional testing reveals how the body is actually performing — and it is functional impairment, not structural imaging findings, that determines treatment direction and rehabilitation goals. The experienced clinician uses imaging to confirm or exclude specific structural diagnoses that clinical testing has already raised as probable — not as a substitute for thorough functional assessment.
References & Further Reading
- Cyriax J. Textbook of Orthopaedic Medicine, Vol 1. 8th ed. London: Baillière Tindall; 1982.
- Brinjikji W, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811–816.
- Harris-Hayes M, et al. Movement-pattern training to improve function in people with chronic hip joint pain. J Orthop Sports Phys Ther. 2012;42(8):645–655.